US FDA’s Non-Cancer Accelerated Approval Drugs Get Their Own Public Databases

Accelerated Approval Program web page links to searchable databases for accelerated approvals of infectious disease products, vaccines, and other nonmalignant indications. New databases, which include products that converted to regular approval or were withdrawn, are modeled after Oncology Center of Excellence’s cancer drug databases that debuted in 2021.

Fingers typing
FDA's non-cancer accelerated approvals are now readily searchable online. • Source: Shutterstock

Details about non-oncology drugs and vaccines under accelerated approval, as well as withdrawn drugs under the expedited pathway, are now easier to find thanks to some new US Food and Drug Administration publicly searchable databases.

The agency’s Accelerated Approval Program web page includes links to databases listing ongoing accelerated approvals for infectious disease...

Read the full article – start your free trial today!

Join thousands of industry professionals who rely on Pink Sheet for daily insights

  • Start your 7-day free trial
  • Explore trusted news, analysis, and insights
  • Access comprehensive global coverage
  • Enjoy instant access – no credit card required

More from Review Pathways

More from Pathways & Standards